DYRK4

Dual specificity tyrosine-phosphorylation-regulated kinase 4 (DYRK4) is a serine/threonine kinase with limited tissue expression, predominantly in stage VIII postmeiotic spermatids^[1]. Mechanistically, DYRK4 participates in phosphorylation-mediated regulation of transcription factors, contributing to the fine-tuning of spermiogenesis, although knockout models indicate functional redundancy among DYRK isoforms^[1]. Multiple splice variants of DYRK4 exhibit distinct subcellular localizations and enzymatic activities, including a nuclear-localized variant that interacts with importin α3/α5, and a cytoplasmic variant with reduced catalytic activity due to a three-amino-acid deletion in subdomain XI^[2]. DYRK4 differs from other DYRK family members in substrate specificity, as it lacks the arginine P-3 preference characteristic of DYRK1A, highlighting isoform-specific functional divergence^[2]. Experimental modulation of DYRK4 activity has been explored using selective DYRK inhibitors developed for related isoforms, with potential utility in dissecting isoform-specific roles in cell differentiation and metabolic regulation^[3][4][5]. Although no disease phenotype is directly associated with DYRK4 deficiency, its restricted expression and splice-dependent activity suggest applications as a model for investigating testis-specific kinase regulation and isoform-selective therapeutic targeting^[1][2].